Abstract
Current shortages of Filtering Facepiece Respirators (FFRs) have created a demand for effective methods for N95 decontamination and reuse. Before implementing any reuse strategy it is important to determine what effects the proposed method has on the physical functioning of the FFR. Here we investigate the effects of two potential methods for decontamination; dry heat at 95 °C, and autoclave treatments. We test both fit and filtration efficiency for each method. For the dry heat treatment we consider the 3M 1860, 3M 1870, and 3M8210+ models. After five cycles of the dry heating method, all three FFR models pass both fit and filtration tests, showing no degradation. For the autoclave tests we consider the 3M 1870, and the 3M 8210+. We find significant degradation of the FFRs following the 121 °C autoclave cycles. The molded mask tested (3M 8210+) failed fit testing after just 1 cycle in the autoclave. The pleated (3M 1870) mask passed fit testing for 5 cycles, but failed filtration testing. The 95 °C dry heat cycle is scalable to over a thousand masks per day in a hospital setting, and is above the temperature which has been shown to achieve the requisite 3 log kill of SARS-CoV-2[1], making it a promising method for N95 decontamination and reuse.
Competing Interest Statement
Steven Chu and Yi Cui are the co-founders of 4C Air and owns the shares of 4C Air. Steven Chu and Yi Cui reports non-financial support from 4C Air; In addition, Steven Chu and Yi Cui has a patent PCT /US2015/065608 licensed to 4C Air. 4C Air tested face masks from several manufacturers that include 4C Air's masks and those of other manufacturers.
Funding Statement
We acknowledge and appreciate the support of the Heising-Simons foundation. Steven Chu and Yi Cui are founders of the for-profit start-up company 4C Air, Inc. Lei Liao and Wang Xiao are employed by the company 4C Air, Inc. directly.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data associated with this work is included in the manuscript.
